This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Skin of upper limb, including shoulder
DOID EFO MESH SNOMED Endpoint Browser
CD2_BENIGN_SKIN_UPPERLIMB
skin neoplasm: A benign or malignant tumor involving the skin. Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma. Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
573
Check minimum number of events None
573
Include endpoints None
573
Remove individuals based on genotype QC
548
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Benign neoplasm: Skin of upper limb, including shoulder based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Skin of upper limb, including shoulder (controls excluding all cancers)
- Other benign neoplasms of skin (controls excluding all cancers)
- Other benign neoplasms of skin
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 548 | 309 | 239 |
Unadjusted prevalence (%) | 0.13 | 0.13 | 0.13 |
Mean age at first event (years) | 48.71 | 46.65 | 51.38 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_SKIN_UPPERLIMB – Benign neoplasm: Skin of upper limb, including shoulder
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Skin of upper limb, including shoulder
↥Endpoint not on priority list, no data to show.